Catalyst Wire Dossier Catalyst Wire Dossier

Bellicum gene-modified donor T-cells

· Bellicum Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bellicum gene-modified donor T-cells, covering 2023-01-04 to 2023-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant [Phase 1, Phase 2]

See pricing